0001209191-21-026777.txt : 20210415
0001209191-21-026777.hdr.sgml : 20210415
20210415085728
ACCESSION NUMBER: 0001209191-21-026777
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210415
FILED AS OF DATE: 20210415
DATE AS OF CHANGE: 20210415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gibson Christopher
CENTRAL INDEX KEY: 0001856369
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40323
FILM NUMBER: 21827432
MAIL ADDRESS:
STREET 1: C/O RECURSION PHARMACEUTICALS
STREET 2: 41 S. RIO GRANDE STREET
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RECURSION PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001601830
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 464099738
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41S RIO GRANDE STREET
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84101
BUSINESS PHONE: (385) 269-0203
MAIL ADDRESS:
STREET 1: 41S RIO GRANDE STREET
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84101
FORMER COMPANY:
FORMER CONFORMED NAME: Recursion Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20140305
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2021-04-15
0
0001601830
RECURSION PHARMACEUTICALS, INC.
RXRX
0001856369
Gibson Christopher
41 S. RIO GRANDE STREET
SALT LAKE CITY
UT
84101
1
1
1
0
Chief Executive Officer
Common Stock
9262500
D
Common Stock
150000
I
By Gibson Family Trust
Series A Preferred Stock
0.00
Common Stock
22698
D
Series A-1 Preferred Stock
0.00
Common Stock
32685
D
Stock Option (Right to Buy)
2.47
2030-12-30
Common Stock
1500000
D
Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class B Common Stock.
Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Series A Preferred Stock and Series A-1 Preferred Stock shall automatically convert into Class B Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and has no expiration date.
One forty-eighth (1/48th) of the shares subject to the award shall vest one month after December 31, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.
/s/ Christopher Gibson
2021-04-14